BREAKING NEWS

BREAKING NEWS

Drugmaker Novo Nordisk fourth-quarter profit lags forecast

Drugmaker Novo Nordisk fourth-quarter profit lags forecast
@ Copyright :
POOL New(Reuters)
Text size Aa Aa

COPENHAGEN (Reuters) - Denmark's Novo Nordisk <NOVOb.CO> posted fourth-quarter operating profit below forecasts on Friday, and said it would submit its oral semaglutide drug, an important growth hope, for U.S. approval in the first quarter.

Novo, the world's top maker of diabetes drugs, posted a quarterly operating profit of 10.8 billion Danish crowns ($1.66 billion), below an average 11.3 billion crowns forecast in a Reuters poll of analysts..

(Reporting by Stine Jacobsen; Editing by Jacob Gronholt-Pedersen)

euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on euronews.com for a limited time.